Adam Fitzgerald
Family Medicine · Saint Louis, MONPI 1982831657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 61.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $777 and has fallen 92.7% since, to $57 in 2024.
Across 149 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$203
- Amgen$140
- Pfizer$108
- AstraZeneca$108
- Sanofi-aventis U.S. LLC$100
- plus $325 from 13 others
What the payments were for
- Food & beverage$2,579100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,595 |
| Novo Nordisk | 15 | $203 |
| Amgen | 9 | $140 |
| Pfizer | 7 | $108 |
| AstraZeneca | 8 | $108 |
| Sanofi-aventis U.S. LLC | 7 | $100 |
| Lilly USA, LLC | 4 | $66 |
| Boehringer Ingelheim | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Amarin Pharma, Inc. | 2 | $25 |
| GSK | 2 | $24 |
| Johnson & Johnson | 2 | $23 |
| BD | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Circassia Inc. | 1 | $11 |
How this compares
$2,579 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $6,922 |
| Atorvastatin Calcium | 105 | $1,278 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $677 |
| Levothyroxine Sodium | 39 | $571 |
| Gabapentin | 20 | $525 |
| Lisinopril | 60 | $409 |
| Omeprazole | 27 | $358 |
| Amlodipine Besylate | 49 | $323 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $320 |
| ClopidogrelClopidogrel Bisulfate | 15 | $257 |
| Torsemide | 21 | $199 |
| Metoprolol Succinate | 20 | $174 |
| Metoprolol Tartrate | 19 | $152 |
| Losartan Potassium | 26 | $132 |
| Metformin Hcl | 28 | $127 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.